During the past decade, Southeast Texas Clinical Research Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southeast Texas Clinical Research Center" #1 sponsor was "Boston Scientific Corporation" with 4 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Arbor Pharmaceuticals, Inc." with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southeast Texas Clinical Research Center" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Southeast Texas Clinical Research Center" are "Hypertension" (3 trials), "Atrial Fibrillation" (2 trials), "Acute Coronary Syndrome" (1 trials), "Arthritis, Rheumatoid" (1 trials) and "Cardiac Resynchronization Therapy" (1 trials). Many other conditions were trialed in "Southeast Texas Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Southeast Texas Clinical Research Center" are "Drug" (7 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Darusentan" (2 trials), "Guanfacine" (2 trials), "ACUITY X4 quadripolar coronary venous lead and RELIANCE 4-FRONT defibrillation lead" (1 trials), "Apixaban" (1 trials) and "Azilsartan Medoxomil High-dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southeast Texas Clinical Research Center" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Southeast Texas Clinical Research Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Southeast Texas Clinical Research Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Southeast Texas Clinical Research Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".